Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06YDW
|
|||
| Former ID |
DNC013812
|
|||
| Drug Name |
23-hydroxybetulinic acid
|
|||
| Synonyms |
85999-40-2; CHEBI:69580; 3,23-dihydroxy-20(29)-lupen-28-oic acid; Anemosapogenin; 23-Hydroxybetulinicacid; 23-hydroxy betulic acid; CHEMBL251308; 23-Hydroxybetulinic Acid, 25; BDBM23209; MolPort-039-338-114; HXWLKAXCQLXHML-WGOZWDAUSA-N; HY-N0566; EBD870843; ZINC14980302; AKOS032944876; CS-5686; SC-72875; 23-Hydroxybetulinic acid, > 3I(2),23-dihydroxylup-20(29)-en-28-oic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C30H48O4
|
|||
| Canonical SMILES |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O)C)C(=O)O
|
|||
| InChI |
1S/C30H48O4/c1-18(2)19-9-14-30(25(33)34)16-15-28(5)20(24(19)30)7-8-22-26(3)12-11-23(32)27(4,17-31)21(26)10-13-29(22,28)6/h19-24,31-32H,1,7-17H2,2-6H3,(H,33,34)/t19-,20+,21+,22+,23-,24+,26-,27-,28+,29+,30-/m0/s1
|
|||
| InChIKey |
HXWLKAXCQLXHML-WGOZWDAUSA-N
|
|||
| CAS Number |
CAS 85999-40-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:69580
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycogen phosphorylase muscle form (GP) | Target Info | Inhibitor | [1] |
| BioCyc | Glycogenolysis | |||
| KEGG Pathway | Starch and sucrose metabolism | |||
| Metabolic pathways | ||||
| Insulin signaling pathway | ||||
| Glucagon signaling pathway | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| WikiPathways | Glycogen Metabolism | |||
| Metabolism of carbohydrates | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystal... J Med Chem. 2008 Jun 26;51(12):3540-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.